SKC (011790) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
23 Jun, 2026Executive summary
Q3 2024 revenue reached KRW 462.3 bn, down 2.2% sequentially but up 22.5% year-over-year.
Net profit improved to -49.5 bn, a 57.2% sequential increase and 24.5% year-over-year improvement.
Operating profit remained negative at -62.0 bn, with EBITDA at -16.7 bn.
Report covers Q3 2024 (Jan 1–Sep 30) for a diversified materials and chemicals group.
Strategic focus on global expansion, R&D, and portfolio optimization, including divestitures and acquisitions.
Financial highlights
Q3 2024 consolidated revenue: ₩1,350.2B, down from ₩1,570.8B YoY.
Operating loss: ₩200.8B (vs. loss of ₩216.3B YoY); net loss: ₩337.0B (vs. net loss of ₩282.8B YoY).
Gross profit for Q3 was -1.1 bn, with COGS at 463.4 bn.
Profit before tax was -112.7 bn, a 24.9% sequential improvement.
Cash and equivalents: ₩382.2B; total assets: ₩6,752.5B; total liabilities: ₩4,346.1B.
Outlook and guidance
Higher utilization in Malaysia expected due to new shipments and long-term contracts.
Battery materials: global demand for copper foil expected to grow with EV/ESS market, but short-term demand remains soft.
Semiconductor materials: continued R&D and market share expansion in CMP Pad and test sockets; memory market recovery expected in 2025.
Vietnam plant expansion to meet increased demand from major tech customers.
Initial CHIPS Act subsidy grant anticipated by year-end.
Latest events from SKC
- Revenue rebounded sequentially but losses continued as global expansion and R&D investment grew.011790
Q2 202423 Jun 2026 - Revenue up 9.9% YoY, losses narrowed, and new supply deals and divestitures boost outlook.011790
Q1 202523 Jun 2026 - Revenue up 14% YoY in 3Q25, but nine-month revenue fell amid restructuring and asset sales.011790
Q3 202523 Jun 2026 - Revenue up in 2Q25, losses narrowed, and portfolio shifts support battery and semiconductor growth.011790
Q2 202523 Jun 2026 - Revenue up 13.4% YoY, operating loss narrowed, and EBITDA turned positive in 1Q 2026.011790
Q1 202622 Jun 2026 - 2024 saw higher revenue but deeper losses, with 2025 targeting sales recovery and cost control.011790
Q4 202420 Feb 2026 - 4Q25 saw revenue growth but deeper losses, with 2026 targeting recovery and expansion.011790
Q4 202520 Feb 2026